The Medicines Company: "Blockbuster Potential" 2 hours ago The Medicines Company (MDCO) announced that the Independent Data Monitoring Committee (IDMC) for the... John McCamant Tickers: MDCO
Aurinia Targets Lupus Nephritis and Dry Eye 07/18/2018 5:00 am EST Aurinia Pharmaceuticals (AUPH) is a clinical stage biopharmaceutical company focused on developing a... Tom Bishop Tickers: AUPH
Illumina: A Bright Light in Genetic Analysis 07/17/2018 5:00 am EST With annual revenues of $2.8 billion, Illumina (ILMN) makes sequencing- and array-based solutions fo... Leo Fasciocco Tickers: ILMN
Intec Pharma: Parkinson's, Insomnia and a Cannabidiol Platform 07/17/2018 5:00 am EST Over the past couple of decades our most profitable sector has been biotech stocks. We use a process... Bill Mathews Tickers: NTEC
AbbVie: More Than Humira 07/12/2018 5:00 am EST Pharmaceutical giant AbbVie Inc. (ABBV) is down 7% since since last month; we see the selloff as mor... Ian Wyatt Tickers: ABBV
Top Picks' Mid-Year Winners: Utah Medical Devices 07/06/2018 5:00 am EST In MoneyShow's Top Picks 2018 report published at the start of the year, money manager Jim Fink chos... James Fink Tickers: UTMD
Top Picks' Mid-Year Winners: Integra Life Sciences 07/05/2018 5:00 am EST In MoneyShow's Top Picks 2018 report published at the start of the year, David Toung chose Integra L... David Toung Tickers: IART
Bristol-Myers Squibb: Value in Oncology 06/21/2018 5:00 am EST Early last year, tough talk about drug price controls from the fledgling Trump administration sent B... Todd Shaver Tickers: BMY
5 Favorite Healthcare REITs 06/15/2018 5:00 am EST Real Estate Investment Trusts, or REITs, are a great source of regular income for retirees and other... Chloe Jensen Tickers: CHCT DOC HTA MPW OHI
AbbVie: "Growing Like Gangbusters" 06/14/2018 5:00 am EST I’d like to recommend a big pharma stock that has a strong outlook but is selling off its high... Mark Skousen Tickers: ABBV
"Sleep Well" Value Bets in Pharma: Amgen & J&J 06/12/2018 5:00 am EST We continue to think that the only problem with market timing is getting the timing right, so we bel... John Buckingham Tickers: AMGN JNJ
Madrigal Pharmaceuticals: A Top Stock Picker's Update 06/05/2018 5:00 am EST Two weeks ago, at the Las Vegas Money Show, John McCamant was given our "stock picker of the year aw... John McCamant Tickers: MDGL
John McCamant: Investing in Biotech 06/04/2018 3:45 pm EST At MoneyShow, John McCamant on investing in biotech. We recommend diversification. Second or third t... McCamant, John Duration: 7:51
John McCamant: MoneyShow Top Picks 2018 06/01/2018 3:25 pm EST At MoneyShow Las Vegas, John McCamant is honored with the 2018 MoneyShow Top Picks Award for his rec... McCamant, John Duration: 4:27
Sangamo: Steady Progress in Gene Editing 05/30/2018 5:00 am EST At MoneyShow Las Vegas May 14-16, biotech sector expert John McCamant was given the show’s &ld... John McCamant Tickers: SGMO
Aurinia: Dry Eye to Lupus 05/29/2018 5:00 am EST Aurinia Pharmaceuticals (AUPH) is a clinical stage biopharmaceutical company focused on developing a... Tom Bishop Tickers: AUPH
Teledoc: House Calls Online 05/29/2018 5:00 am EST The medical industry is ripe for innovation, and perhaps nowhere more so than here in the U.S., wher... Michael Cintolo Tickers: TDOC
Sarepta: Biotech Targets Muscular Dystrophy 05/22/2018 5:00 am EST Mid-cap biotech Sarepta Therapeutics (SRPT) develops treatments for Duchenne muscular dystrophy (DMD... Michael Cintolo Tickers: SRPT
AstraZeneca: Blockbuster Potential in Lung Cancer? 05/16/2018 5:00 am EST Lung cancer remains the leading cause of cancer death and the most common form of the disease detect... Todd Shaver Tickers: AZN
Bristol-Myers Squibb: A Pharma Favorite 05/10/2018 5:00 am EST The biotechnology and pharmaceutical stocks have seen some tough times of late, especially Editor&rs... Charles Carlson Tickers: BMY
